Cargando…
Apolipoprotein L1 gene variants associate with prevalent kidney but not prevalent cardiovascular disease in the Systolic Blood Pressure Intervention Trial
Apolipoprotein L1 gene (APOL1) G1 and G2 coding variants are strongly associated with chronic kidney disease (CKD) in African Americans. Here APOL1 association was tested with baseline estimated glomerular filtration rate (eGFR), urine albumin:creatinine ratio (UACR), and prevalent cardiovascular di...
Autores principales: | Langefeld, Carl D., Divers, Jasmin, Pajewski, Nicholas M., Hawfield, Amret T., Reboussin, David M., Bild, Diane E., Kaysen, George A., Kimmel, Paul L., Raj, Dominic, Ricardo, Ana C., Wright, Jackson T., Sedor, John R., Rocco, Michael V., Freedman, Barry I. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4281289/ https://www.ncbi.nlm.nih.gov/pubmed/25029429 http://dx.doi.org/10.1038/ki.2014.254 |
Ejemplares similares
-
APOL1 Renal-Risk Variants Do Not Associate With Incident Cardiovascular Disease or Mortality in the Systolic Blood Pressure Intervention Trial
por: Freedman, Barry I., et al.
Publicado: (2017) -
Response to Comment on Chan et al. FGF23 Concentration and APOL1 Genotype Are Novel Predictors of Mortality in African Americans With Type 2 Diabetes. Diabetes Care 2018;41:178–186
por: Divers, Jasmin, et al.
Publicado: (2018) -
Prevalence and determinants of electrocardiographic abnormalities in African Americans with type 2 diabetes
por: Sellers, Matthew B., et al.
Publicado: (2014) -
Ethnic Differences in the Relationship Between Albuminuria and Calcified Atherosclerotic Plaque: The African American-Diabetes Heart Study
por: Divers, Jasmin, et al.
Publicado: (2010) -
Intensive systolic blood pressure treatment remodels brain perivascular spaces: A secondary analysis of the Systolic Pressure Intervention Trial (SPRINT)
por: Kern, Kyle C., et al.
Publicado: (2023)